Brain imaging screening in metastatic breast cancer: patients’ and physicians’ perspectives

Leonor Vasconcelos de Matos; Mette van Ramshorst; Volkmar Müller; Elisa Agostinetto; Sabine Linn; Matteo Lambertini; Véronique Dièras; Fanny Le Du; Sofía Braga; Carmen Criscitiello; Katarzyna J. Jerzak; Gil Morgan; Sara Y. Brucker; Patricia von Kroge; Renate Haidinger; Gema Rodríguez Recio; Eva Schumacher-Wulf; Mario Fontes Sousa; Francesco Schettini; Elena Laakmann

doi:10.1016/j.breast.2025.104558

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

These results underline the willingness of patients to know more about the prospects of BM development, in contrast to the lack of routine discussion of this topic by physicians. Further investigation is warranted to demonstrate the clinical utility of routine BIS.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Matos et al. (2025) studied this question.

synapsesocial.com/papers/69dd67f87dbdc4ad1440c8bc https://doi.org/10.1016/j.breast.2025.104558

View Full Paper

Ask AI

Bookmark

Share

Brain imaging screening in metastatic breast cancer: patients’ and physicians’ perspectives

Ask about this paper

Abstract

Discussion

Cite This Study

Brain imaging screening in metastatic breast cancer: patients’ and physicians’ perspectives

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading